ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Aug 07, 2021 00:00 JST
Source:
Science and Technology of Advanced Materials
Hydrogel holds life-giving cells longer
An injection made of a hydrogel containing stem cells could treat damaged tissue following a heart attack.
TSUKUBA, Japan, Aug 06, 2021 - (ACN Newswire) - Heart muscle becomes damaged and cardiac function is affected when blood vessels feeding the heart are blocked. A new stem-cell-carrying hydrogel helps mice recover from this condition, called myocardial infarction, by stimulating formation of new blood vessels. Developed by a team of scientists at Kansai University in Japan, the stem cell delivery system is described in the journal Science and Technology of Advanced Materials.
The hydrogel acts as a scaffold that holds the stem cells in place at the site of injection and keeps them alive for longer. The stem cells produce cytokines that stimulate the formation of blood vessels to help the heart recover. The gel is biodegradable, so it eventually dissolves and is removed by the body.
The team used stem cells derived from fat tissue in their application. These so-called 'adipose-derived stem cells' have already been investigated for treating damaged cardiac tissue from reduced blood flow to the heart, known as myocardial ischemia. The idea is that the stem cells will release stimulating factors to regenerate blood vessels once injected into damaged heart tissue. The problem, though, is that they can't be retained or survive in the tissue long enough. In other studies, scientists have found that injecting cell-free biodegradable hydrogels into damaged heart tissue helps partial recovery of heart functions.
Kansai University bioengineer Yuichi Ohya and his colleagues mixed the two techniques together.
Firstly, they developed hydrogel formulas that can hold stem cells in place for longer periods of time at the site of tissue damage. These hydrogels start off as a solution when they are at room temperature. This makes it easy to mix in the stem cells. When the solution is injected into an organ, it warms to body temperature, triggering its transformation into a gel.
One of their hydrogels was especially good at staying in its gel state. It was made with a combination of molecules, called tri-PCG, with acrolyl groups attached to them. The tri-PCG-acryl was then mixed with a polythiol derivative.
The team added adipose-derived stem cells to the hydrogel and observed, both in petri dishes and inside mouse heart tissue, how long the cells lived and what kinds of genes and substances were produced by the cells.
"The stem cells were able to survive in our injectable hydrogel and released molecules that stimulate blood vessel formation, improving heart function and making it effective for treatment of ischemic heart," says Ohya.
The team next plans to test their therapy on larger animals after confirming its safety, and then to conduct clinical studies in humans. They also plan to investigate using their injectable hydrogel to deliver immune cells to treat cancer or in vaccines to protect against viral infections.
Further information
Yuichi Ohya
Kansai University
Email:
yohya@kansai-u.ac.jp
Paper:
https://www.tandfonline.com/doi/full/10.1080/14686996.2021.1938212%40tsta20.2021.22.issue-BioJ
About Science and Technology of Advanced Materials Journal
Open access journal STAM publishes outstanding research articles across all aspects of materials science, including functional and structural materials, theoretical analyses, and properties of materials.
https://www.tandfonline.com/STAM
Dr. Yoshikazu Shinohara
STAM Publishing Director
Email:
SHINOHARA.Yoshikazu@nims.go.jp
Press release distributed by ResearchSEA for Science and Technology of Advanced Materials.
Source: Science and Technology of Advanced Materials
Sectors: Science & Nanotech, BioTech
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
myBillBook Leverages CleverTap to Elevate Customer Engagement and Drive Revenue Growth
Nov 14, 2024 20:00 JST
ULVAC Launches Oil Rotary Vacuum Pump Gv135
Nov 14, 2024 10:00 JST
MHI Publishes MHI REPORT 2024
Nov 13, 2024 16:52 JST
SoftBank Corp. and Fujitsu Strengthen Partnership for Realization of AI-RAN Commercialization
Nov 13, 2024 12:38 JST
Predictive Heart Monitoring Startup, GPx, Secures New Investment From NEC X; Joins Elev X! Boost Venture Studio Program
Nov 13, 2024 12:05 JST
NEC receives order for next-generation supercomputer system from Japan's National Institutes for Quantum Science and Technology and National Institute for Fusion Science
Nov 13, 2024 11:16 JST
All-New Triton Wins Special Award at the RJC Car of the Year for 2025
Nov 12, 2024 22:09 JST
Toyota: HySE to participate in the Dakar 2025 "Mission 1000 ACT2" with the HySE-X2, to tackle further technical challenges
Nov 12, 2024 20:04 JST
NEC participates in COP29 climate change conference
Nov 12, 2024 19:25 JST
JA Mitsui Leasing and Fujitsu collaborate on simulation-driven field trials to optimize commercial EV adoption and drive decarbonization
Nov 12, 2024 13:57 JST
Macnica publishes Integrated Report on the theme of 'An Introductory Guide to Macnica's Mechanism'
Nov 12, 2024 13:00 JST
Hitachi: Established the Open Source Program Office (OSPO) to Globally Lead the Strategic Utilization of OSS
Nov 11, 2024 10:31 JST
Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024
Nov 08, 2024 10:31 JST
Hitachi High-Tech and University of Tokyo Promote Joint Research for the Practical Application of High-resolution Laser-PEEM in the Semiconductor Field
Nov 07, 2024 18:19 JST
Mitsubishi Motors Acquires Its Own Shares from Nissan
Nov 07, 2024 17:20 JST
Honda Signs Sponsorship Agreement to Provide Electrified Vehicles at World Athletics Championships Tokyo 25
Nov 07, 2024 17:10 JST
Home of Fujitsu joint conservation project designated as first Nationally Certified Sustainably Managed Natural Site in Okinawa
Nov 07, 2024 14:51 JST
NEC and NEC Bio publish foundational work on T Cell Receptor engineering using proprietary generative AI at the Society for Immunotherapy of Cancer annual meeting
Nov 07, 2024 11:40 JST
Anime Tokyo Station 1st Anniversary Event: Celebrating one year since the opening of the new hub for sharing Japanese anime
Nov 07, 2024 11:00 JST
57% of Banking Executives Struggle with Data Silos, Blocking AI-Driven Personalization, CleverTap's New Report Highlights
Nov 06, 2024 15:30 JST
More Latest Release >>
Related Release
Machine learning can predict the mechanical properties of polymers
October 25 2024 23:00 JST
Dual-action therapy shows promise against aggressive oral cancer
July 30 2024 20:00 JST
A new spin on materials analysis
April 17 2024 22:00 JST
Kirigami hydrogels rise from cellulose film
April 12 2024 18:00 JST
Sensing structure without touching
February 27 2024 08:00 JST
Nano-sized probes reveal how cellular structure responds to pressure
November 21 2023 07:00 JST
Machine learning techniques improve X-ray materials analysis
November 17 2023 10:00 JST
A bio-inspired twist on robotic handling
November 14 2023 20:00 JST
GPT-4 artificial intelligence shows some competence in chemistry
October 17 2023 08:00 JST
Closing the loop between artificial intelligence and robotic experiments
August 24 2023 09:00 JST
More Press release >>